Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world propensity score matching study

Category Primary study
JournalFront. Immunol.
Year 2026
This article has no abstract
Epistemonikos ID: cf107aaa2fadb5e294df81f5fafb6e6a34246af0
First added on: Feb 21, 2026